McDermott Will & Emery advised Innate Pharma S.A. in this transaction.Innate Pharma S.A., a clinical-stage biotechnology company specializing in the development of cancer immunotherapies, has signed…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
